WO2004005331A3 - Peptides derived from pep133 (g1p3, 6-16) - Google Patents

Peptides derived from pep133 (g1p3, 6-16) Download PDF

Info

Publication number
WO2004005331A3
WO2004005331A3 PCT/EP2003/006535 EP0306535W WO2004005331A3 WO 2004005331 A3 WO2004005331 A3 WO 2004005331A3 EP 0306535 W EP0306535 W EP 0306535W WO 2004005331 A3 WO2004005331 A3 WO 2004005331A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
pep133
peptides derived
seq
nos
Prior art date
Application number
PCT/EP2003/006535
Other languages
French (fr)
Other versions
WO2004005331A2 (en
Inventor
Guilaine Argoud-Puy
Lydie Bougueleret
Original Assignee
Geneprot Inc
Guilaine Argoud-Puy
Lydie Bougueleret
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geneprot Inc, Guilaine Argoud-Puy, Lydie Bougueleret filed Critical Geneprot Inc
Priority to AU2003249857A priority Critical patent/AU2003249857A1/en
Publication of WO2004005331A2 publication Critical patent/WO2004005331A2/en
Publication of WO2004005331A3 publication Critical patent/WO2004005331A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention provides novel human secreted peptides having an amino acid sequence of SEQ ID NOS 3, 5 and 7. The invention also provides the amidated forms of these polypeptides as SEQ ID NOS 4, 6 and 8, and compositions including polypeptides, polynucleotides, and antibodies specific for these peptides. Also provided are methods for making such compositions, and methods of using the compositions of the invention for diagnosis, prognosis, and treatment of diseases.
PCT/EP2003/006535 2002-07-02 2003-06-20 Peptides derived from pep133 (g1p3, 6-16) WO2004005331A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003249857A AU2003249857A1 (en) 2002-07-02 2003-06-20 Peptides derived from pep133 (g1p3, 6-16)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39369502P 2002-07-02 2002-07-02
US60/393,695 2002-07-02

Publications (2)

Publication Number Publication Date
WO2004005331A2 WO2004005331A2 (en) 2004-01-15
WO2004005331A3 true WO2004005331A3 (en) 2004-06-10

Family

ID=30115627

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/006535 WO2004005331A2 (en) 2002-07-02 2003-06-20 Peptides derived from pep133 (g1p3, 6-16)

Country Status (2)

Country Link
AU (1) AU2003249857A1 (en)
WO (1) WO2004005331A2 (en)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KELLY J M ET AL: "CHARACTERIZATION OF A HUMAN GENE INDUCIBLE BY ALPHA- AND BETA- INTERFERONS AND ITS EXPRESSION IN MOUSE CELLS", EMBO JOURNAL, IRL PRESS, EYNSHAM, GB, vol. 5, no. 7, 1986, pages 1601 - 1606, XP002050158, ISSN: 0261-4189 *
TURRI MARIA-GRAZIA ET AL: "Characterization of a novel minisatellite that provides multiple splice donor sites in an interferon-induced transcript", NUCLEIC ACIDS RESEARCH, vol. 23, no. 11, 1995, pages 1854 - 1861, XP001156214, ISSN: 0305-1048 *

Also Published As

Publication number Publication date
WO2004005331A2 (en) 2004-01-15
AU2003249857A8 (en) 2004-01-23
AU2003249857A1 (en) 2004-01-23

Similar Documents

Publication Publication Date Title
EP1308459A3 (en) Full-length cDNA sequences
EP1440981A3 (en) Full-length human cdna
WO2007002261A3 (en) IL-1β BINDING ANTIBODIES AND FRAGMENTS THEREOF
EP2258383A3 (en) Antigenic peptides derived from telomerase
WO2001038486A3 (en) Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies
WO2000066067A3 (en) Ibd-associated microbial antigens and methods of using same
WO2003063760A3 (en) Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
IL135688A0 (en) Human checkpoint kinase, hcds1, compositions and methods
WO2004076614A3 (en) Human nucleic acid sequences obtained from prostatic carcinomas
EP1447413A3 (en) Full-length human cDNA
WO2002092758A8 (en) Gastrokines and derived peptides including inhibitors
GB0210783D0 (en) Anti-microbial polypeptides
WO2004005331A3 (en) Peptides derived from pep133 (g1p3, 6-16)
WO2001032878A3 (en) A novel polypeptide hormone phosphatonin
WO2003070770A3 (en) Engineered human kunitz-type protease inhibitor
WO2005116658A3 (en) Method for determining a tissue degradation process by detection of comp neoepitopes
WO1998041538A3 (en) Novel human cytokine/steroid receptor protein
EP0723014A3 (en) cDNA of DOCK180 gene and DOCK180 protein
WO2002036633A3 (en) Human 7tm proteins and polynucleotides encoding the same
WO2000042165A3 (en) Bone marrow-specific protein
WO2005019407A3 (en) Polynucleotides, polypeptides and antibodies and use thereof in treating tsg101-associated diseases
WO2002016435A3 (en) Human 7tm proteins and polynucleotides encoding the same
EP1225183A3 (en) Human G-protein coupled receptor
WO2001057086A3 (en) Novel human g protein coupled receptor proteins and polynucleotides encoding the same
AU4956901A (en) Novel human 7tm proteins and polynucleotides encoding the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP